Low vs. high-intensity occlusion therapy for mild/moderate amblyopia

  • Research type

    Research Study

  • Full title

    Low vs. high-intensity occlusion therapy for mild/moderate amblyopia: A randomised, controlled feasibility trial

  • IRAS ID

    266637

  • Contact name

    Dipesh Patel

  • Contact email

    dipesh_patel@ucl.ac.uk

  • Sponsor organisation

    UCL GOS Institute of Child Health

  • ISRCTN Number

    ISRCTN44138928

  • Duration of Study in the UK

    3 years, 11 months, 31 days

  • Research summary

    AIM
    This study will compare low vs. high treatment doses for patching (occlusion therapy) children with lazy eye (amblyopia) to support the design of a future study.

    BACKGROUND
    Amblyopia is a condition that affects about 230,000 children under 7 years in the UK. It affects the way eyesight develops, causing blurred vision. Treatment involves prescribing glasses, if required, and monitoring for improvement. In children whose vision does not correct fully with glasses alone, patching (covering the better-seeing or normal eye) is then commonly used.
    Patching is often difficult for children and many suffer from bullying. Treatment is often unsuccessful.
    2 hours daily patching (low-intensity treatment) usually takes a number of months, and sometimes years. Adherence to treatment drops dramatically over time.
    High-intensity treatment could produce faster improvements, and better final outcomes, shortening treatment and reducing costs, but there isn’t enough information about the treatment to design a study comparing low to high-intensity patching.

    RESEARCH QUESTION
    In children aged 4 years and older with amblyopia, does low or high-intensity patching produce a better vision outcome?
    This study will provide the necessary information to address this question in a clinical trial.

    METHODS
    We will:
    1. Conduct a small-scale feasibility study to see if it’s possible to run a larger trial.
    We will approach children and their families at Moorfields Eye Hospital to take part in the study. They will be randomly asked to perform either low or high-intensity patching. Treatment will be monitored with an electronic device in their patch. Children will have their vision tested in clinics for 12 months.

    2. Develop ways to address known problems with treatment adherence.
    We will interview patients and their parents and work together with the public, psychologists and specialist implementation scientists to improve treatment adherence.

    3. Design a clinical trial and apply for funding.

  • REC name

    London - Bloomsbury Research Ethics Committee

  • REC reference

    20/LO/0093

  • Date of REC Opinion

    27 May 2020

  • REC opinion

    Further Information Favourable Opinion